Piperacillin/tazobactam + Levofloxacin

PreclinicalSmall molecule

Piperacillin/tazobactam + Levofloxacin is one of 25 small molecule programs targeting Pneumonia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumoniaActive, not recruiting

PneumoniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

Prevacid

Takeda

Preclinical

1 2

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

12 3

Zantac 150

CChattem

Preclinical

2 4

Alka-Seltzer

AAbbott

Preclinical

1 5

Pepcid

KKenvue Brands

Preclinical

1 6

Aciphex

Akero Therapeutics

Preclinical

1 7

Mucinex

AAultman Health Foundation

Preclinical

1 8

Tagamet

DDT MedTech, LLC

Preclinical

1 9

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 10

PCV13

Sanofi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

N/ANot yet recruiting

Pneumonia

NCT06977347

Clinical

Trials by Indication[1]

Pneumonia1 trial

Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

Not yet recruiting·CCHOSEOK YOON·N/A·NCT06977347·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Piperacillin/tazobactam + Levofloxacin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Piperacillin/tazobactam + Levofloxacin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Piperacillin/tazobactam + Levofloxacin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — CHOSEOK YOON company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCHOSEOK YOON

Piperacillin/tazobactam + Levofloxacin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Pneumonia1 trial

References

Drug Info

Quick Facts

Related News